Mycobacterium bovis BCG vaccine induces non-specific immune responses in Japanese flounder against Nocardia seriolae

Fish and Shellfish Immunology

Volumn 33, Issue 2, 2012, Pages 243-250

  Kato, Goshi ^a   Kondo, Hidehiro ^a   Aoki, Takashi ^a   Hirono, Ikuo ^a  

^a TOKYO UNIVERSITY OF MARINE SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Japanese flounder; Lysozyme; Microarray; Mycobacterium bovis BCG; Nocardia seriolae

Indexed keywords

MAMMALIA; MICROCOCCUS LUTEUS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG; NOCARDIA; NOCARDIA SERIOLAE; PARALICHTHYS OLIVACEUS; PLEURONECTOIDEI;

EID: 84863200578     PISSN: 10504648     EISSN: 10959947     Source Type: Journal    
DOI: 10.1016/j.fsi.2012.05.002     Document Type: Article

References (42)

1. Kusuda R., Nakagawa A. Nocardial infection of cultured yellowtail. Fish Pathol 1978, 13:25-31.
2. Kudo T., Hatai K., Seino A. Nocardia seriolae sp. nov. causing nocardiosis of cultured fish. Int Syst Bacteriol 1988, 38:173-178.
3. Lewis S., Chinabut S. Mycobacteriosis and nocardiosis. Viral, bacterial and fungal infection 2011, vol. 3:397-423. CAB International, Oxfordshire. 2nd ed. P.T.K. Woo, D.W. Bruno (Eds.).
4. Matsuzato T. Nocardiosis of cultured yellowtail. Fish Pathol 1978, 13:33-34.
5. Ponninghaus J.M., Fine P.E., Sterne J.A., Wilson R.J., Msosa E., Gruer P.J., et al. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet 1992, 339:636-639.
6. Portaels F., Aguiar J., Debacker M., Steunou C., Zinsou C., Guedenon A., et al. Prophylactic effect of Mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli ulcer). Clin Diagn Lab Immunol 2002, 9:1389-1391.
7. Portaels F., Aguiar J., Debacker M., Guedenon A., Steunou C., Zinsou C., et al. Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease. Infect Immun 2004, 72:62-65.
8. Nackers F., Dramaix M., Johnson R.C., Zinsou C., Robert A., DE Biurrun Bakedano E., et al. BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin. Am J Trop Med Hyg 2006, 75:768-774.
9. Smelt A.H.M., Rees R.J.W., Liew F.Y. Induction of delayed-type hypersensitivity to Mycobacterium leprae in healthy individuals. Clin Exp Immunol 1981, 44:501-506.
10. Lozes E., Denis O., Drowart A., Jurion F., Palfliet K., Vanonckelen A., et al. Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-group. Scand J Immunol 1997, 46:16-26.
11. Kwapinski J.B. Antigenic structure of the actinomycetales. VII. Chemical and serological similarities of cell walls from 100 actinomycetales strains. J Bacteriol 1964, 88:1211-1219.
12. Ximenez C., Melendro E.I., Gonzalez-Mendoza A., Garcia A.M., Martinez A., Ortiz-Ortiz L. Resistance to Nocardia brasiliensis infection in mice immunized with either nocardia or BCG. Mycopathologia 1980, 70:117-122.
13. Kato G., Kato K., Saito K., Pe Y., Kondo H., Aoki T., et al. Vaccine efficacy of Mycobacterium bovis BCG against Mycobacterium sp. infection in amberjack Seriola dumerili. Fish Shellfish Immunol 2011, 30:467-472.
14. Kato G., Kondo H., Aoki T., Hirono I. BCG vaccine confers adaptive immunity against Mycobacterium sp. infection in fish. Dev Comp Immunol 2010, 34:133-140.
15. Luo Y., Knudson M.J. Mycobacterium bovis bacillus calmette-guérin-induced macrophage cytotoxicity against bladder cancer cells. Clin Dev Immunol 2010, 357591.
16. Luo Y., Yamada H., Evanoff D.P., Chen X. Role of Th1-stimulating cytokines in bacillus calmette-guérin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells. Clin Exp Immunol 2006, 146:181-188.
17. Cavallo G.P., Elia M., Giordano D., Baldi C., Cammarota R. Decrease of specific and total IgE levels in allergic patients after BCG vaccination. Arch Otolaryngol Head Neck Surg 2002, 128:1058-1060.
18. Harada M., Magara-Koyanagi K., Watarai H., Nagata Y., Ishii Y., Kojo S., et al. IL-21-induced Be{open} cell apoptosis mediated by natural killer T cells suppress IgE responses. J Exp Med 2006, 203:2929-2937.
19. Martineu A.R., Newton S.M., Wilkinson K.A., Kampmann B., Hall B.M., Nawroly N., et al. Neutrophil-mediated innate immune resistance to mycobacteria. J Clin Invest 2007, 117:1988-1994.
20. Kanetsuna F. Effect of lysozyme on mycobacteria. Microbiol Immunol 1980, 24:1151-1162.
21. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
22. Peto R., Pike M.C., Armitage P., Breslow N.E., Cox D.R., Howard S.V., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977, 35:1-39.
23. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998, 95:14863-14868.
24. Ito Y., Yamada H., Imoto T. Colorimetric assay for lysozyme using Micrococcus luteus labeled with a blue dye, Remazol brilliant blue R, as a substrate. Chem Pharm Bull 1992, 40:1523-1526.
25. Shimahara Y., Yasuda H., Nakamura A., Itami T., Yoshida T. Detection of antibody response against Nocardia seriolae by enzyme-linked immunosorbent assay (ELISA) and a preliminary vaccine trial in yellowtail Seriola quinqueradiata. Bull Eur Assoc Fish Pathol 2005, 25:270-275.
26. Itano T., Kawakami H., Kono T., Sakai M. Live vaccine trials against nocardiosis in yellowtail Seriola quinqueradiata. Aquaculture 2006, 261:1175-1180.
27. Bojalil L.F., Zamora A. Precipitin and skin test in the diagnosis of mycetoma due to Nocardia brasiliensis. Proc Soc Exp Biol Med 1963, 113:40-43.
28. Patel P.J., Lefford M.J. Induction of cell mediated immunity to Mycobacterium leprae in mice. Infect Immun 1977, 19:87-93.
29. Ishibashi T., Harada Y., Harada S., Yamada H., Takamoto M., Sugiyama K. Mode of immunopotentiating action of BCG: persistence and spread of BCG infection. Jpn J Exp Med 1978, 48:227-232.
30. + T lymphocytes in control of Mycobacterium tuberculosis infection. Microbes Infect 2005, 7:776-788.
31. + T cell homeostasis. J Immunol 2006, 176:735-739.
32. Pasternack M.S., Eisen H.N. A novel serine esterase expressed by cytotoxic T lymphocytes. Nature 1985, 314:743-745.
33. Stenger S., Mazzaccaro R.J., Uyemura K., Cho S., Barnes P.F., Rosat J.P., et al. Differential effects of cytolytic T cell subsets on intracellular infection. Science 1997, 276:1684-1687.
34. Carroll M.V., Lack N., Sim E., Krarup A., Sim R.B. Multiple routes of complement activation by Mycobacterium bovis BCG. Mol Immunol 2009, 46:3367-3378.
35. Nonaka M., Smith S.L. Complement system of bony and cartilaginous fish. Fish Shellfish Immunol 2000, 10:215-228.
36. Sunyer J.O., Boshra H., Lorenzo G., Parra D., Freedman B., Bosch N. Evolution of complement as an effecter system in innate and adaptive immunity. Immunol Res 2003, 27:549-564.
37. Sunyer J.O., Zarkadis I., Sarrias M.R., Hansen J.D., Lambris J.D. Cloning, structure, and function of two rainbow trout Bf molecules. J Immunol 1998, 161:4106-4114.
38. Keshav S., Chung P., Milon G., Gordon S. Lysozyme is an inducible marker of macrophage activation in murine tissues as demonstrated by in situ hybridization. J Exp Med 1991, 174:1049-1058.
39. Dhople A.M. Effect of lysozyme on Mycobacterium leprae. Lepr India 1983, 55:455-464.
40. Gordon R.E., Barnett D.A. Resistance to rifampin and lysozyme of strains of some species of mycobacterium and nocardia as a taxonomic tool. Int J Syst Bacteriol 1977, 27:176-178.
41. Near K.A., Lefford M.J. Use of serum antibody and lysozyme levels for diagnosis of leprosy and tuberculosis. J Clin Microbiol 1992, 30:1105-1110.
42. Selvaraj P., Kannapiran M., Kurian S.M., Narayanan P.R. Effect of plasma lysozyme on live Mycobacterium tuberculosis. Curr Sci 2001, 81:201-203.